Results 1 to 10 of about 2,229,300 (191)

Activated immune cells present a lung interstitial-to-airway/alveolar cross-compartment sharing pattern in severe pneumonia. [PDF]

Clin Transl Med
Zhao Y, Gong L, Yu H, Zhang S, Yang G, Wang C, Wang W, Cai X, Wang Y.   +8 more
europepmc   +1 more source

An Adjudication Protocol for Severe Pneumonia.

Open Forum Infectious Diseases, 2023
Abstract Background Clinical end points that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. The utility of a protocolized adjudication procedure to determine meaningful end points in severe pneumonia has not been well described.
Chiagozie Pickens
exaly   +3 more sources

Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China

Emerging Microbes and Infections, 2022
Jing Zhang, Hua Zhou, Min Zhou
exaly  

Analysis of mortality risk factors in children with severe adenovirus pneumonia: A single-center retrospective study

Pediatrics and Neonatology, 2022
Huifeng Fan, Di-Yuan Yang
exaly  

Sarilumab use in severe SARS-CoV-2 pneumonia

EClinicalMedicine, 2020
Laura Gigante, Massimo Fantoni, Simone Perniola   +2 more
exaly  

Incidence and Risk Factors for Severe Pneumonia in Children Hospitalized with Pneumonia in Ujjain, India

International Journal of Environmental Research and Public Health, 2020
Ashish Pathak, Aditya Mathur
exaly  

American Journal of Respiratory and Critical Care Medicine

American Journal of Respiratory and Critical Care Medicine, 2005
Francesco Blasi, Reba Umberger, Marco Confalonieri   +2 more
exaly  

Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

American Journal of Respiratory and Critical Care Medicine, 2006
José M Quintana, Inmaculada Gorordo, Amaia Bilbao   +2 more
exaly  

Severe Pneumonia Caused by

Infectious Disease Clinics of North America, 2017
Steven M Opal
exaly